Hologic Stockholders Approve Merger Agreement, Reject Executive Compensation

summarizeSummary

Hologic stockholders approved the proposed merger agreement but rejected the advisory proposal on executive compensation related to the transaction.

check_boxKey Events

• Merger Agreement Approved

  Stockholders overwhelmingly approved the Agreement and Plan of Merger, dated October 21, 2025, with 178,777,739 votes for and 151,271 against.

• Advisory Compensation Proposal Rejected

  The non-binding proposal to approve executive officer compensation related to the merger was not approved, with 115,723,408 votes against versus 60,764,502 for.

• Merger Expected to Close

  The acquisition is anticipated to close in March or April 2026, subject to required regulatory approvals and other customary closing conditions.

auto_awesomeAnalysis

Hologic's stockholders have approved the definitive merger agreement, a critical step towards the company's acquisition by affiliates of Blackstone Inc. and TPG Global, LLC. This approval significantly de-risks the transaction, which is now expected to close in March or April 2026, pending regulatory approvals. However, shareholders rejected, on an advisory basis, the compensation package for named executive officers related to the merger. While non-binding, this rejection signals notable shareholder dissatisfaction with the executive compensation terms, highlighting a governance concern amidst the acquisition process.